Rare Renal Disorders
Browse content by category
Featured insights and resources
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
Urologist Flashcard
This resource is intended to familiarize urologists with the signs and symptoms of primary hyperoxaluria.
PHYOX3 infographic
This infographic summarizes the safety and efficacy of nedosiran in patients with PH1 based 2.5 year interim analysis of the PHYOX3 trial
American Society of Nephrology (ASN) Kidney Week 2023 Materials
View posters and presentations from the ASN Kidney Week 2023 conference on the Novo Nordisk Science Hub.
Find more information
Find product information
Explore our portfolio of products for treating rare renal disorders, including prescribing information, safety data sheets and storage and stability information.
Continuing education
Explore accredited education opportunities for rare renal disorders, supported by Novo Nordisk and provided by third-party organizations.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
